BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15149319)

  • 1. Angiotensin administration stimulates renal 11 beta-hydroxysteroid dehydrogenase activity in healthy men.
    Kerstens MN; van der Kleij FG; Boonstra AH; Sluiter WJ; van der Molen JC; Navis G; Dullaart RP
    Kidney Int; 2004 Jun; 65(6):2065-70. PubMed ID: 15149319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M; Shackleton CH; Mantero F; Stewart PM
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11beta-hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin-II receptor blockade.
    Kerstens MN; Buter H; Navis GJ; Dullaart RP
    Eur J Clin Invest; 2002 Jul; 32(7):513-8. PubMed ID: 12153552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
    Müssig K; Remer T; Fritsche A; Häring HU; Maser-Gluth C
    Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice.
    Ferrari P; Sansonnens A; Dick B; Frey FJ
    Hypertension; 2001 Dec; 38(6):1330-6. PubMed ID: 11751713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.
    Yokokawa A; Takasaka T; Shibasaki H; Kasuya Y; Kawashima S; Yamada A; Furuta T
    Steroids; 2012 Oct; 77(12):1291-7. PubMed ID: 22850318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients.
    Kerstens MN; Riemens SC; Sluiter WJ; Pratt JJ; Wolthers BG; Dullaart RP
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):403-11. PubMed ID: 10762282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
    Hoshiro M; Ohno Y; Masaki H; Iwase H; Aoki N
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):37-45. PubMed ID: 16402926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in cortisol metabolism in insulin-dependent diabetes mellitus: relationship with metabolic control and estimated blood volume and effect of angiotensin-converting enzyme inhibition.
    Dullaart RP; Ubels FL; Hoogenberg K; Smit AJ; Pratt JJ; Muntinga JH; Sluiter WJ; Wolthers BG
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3002-8. PubMed ID: 7559888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
    Palermo M; Delitala G; Mantero F; Stewart PM; Shackleton CH
    J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X; Chen F; Zhu C; Lu Y
    J Pharm Biomed Anal; 2015 Mar; 107():450-5. PubMed ID: 25668797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
    Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome.
    Stiefel P; García-Morillo JS; Jimenez L; Pamies E; Miranda ML; Carneado J; Villar J; Leal-Cerro A
    Endocrine; 2002 Aug; 18(3):279-84. PubMed ID: 12450320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD).
    Mongia A; Vecker R; George M; Pandey A; Tawadrous H; Schoeneman M; Muneyyirci-Delale O; Nacharaju V; Ten S; Bhangoo A
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3622-9. PubMed ID: 22872687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary free cortisol is not a biochemical marker of hypertension.
    Krall P; Carvajal C; Ortiz E; Muñoz C; Garrido JL; Mosso L; Fardella C
    Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily urinary free cortisol and cortisone excretion is associated with urine volume in healthy children.
    Shi L; Maser-Gluth C; Remer T
    Steroids; 2008 Dec; 73(14):1446-51. PubMed ID: 18762206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.